Bulk adjuvant manufacturing
Afrigen’s stated business strategy includes bulk adjuvant manufacturing.
Source: LinkedIn company description · Retrieved October 13, 2026
Afrigen Biologics and Vaccines is a Cape Town-based biotechnology company.
Afrigen’s business strategy focuses on product development, bulk adjuvant manufacturing, and supply and distribution of key biologicals. Afrigen is dedicated to local development and production of adjuvants for human and animal vaccines and biologicals for Africa’s healthcare challenges.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
Afrigen’s stated business strategy includes bulk adjuvant manufacturing.
Source: LinkedIn company description · Retrieved October 13, 2026
Afrigen’s stated business strategy includes supplying and distributing key biologicals.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 15, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.